health news today obesity drugs glp-1 Alarming rise in weight loss drug overdoses The GLP-1 Revolution: How Next-Generation
Description
Klein, D
Acknowledgements The study was supported by the NIHR Oxford Health Biomedical Research Centre (NIHR203316) and the UKRI (MR/T033371/1 and MR/K022202)
It is not uncommon for underwriters, even within the same carrier, to take different approaches when learning that an applicant is using these medications
doi: 10.1111/bph.15860
There was also lower rates of fibrosis progression in the liraglutide group as compared to placebo
